Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;139(6):395-406.
doi: 10.1085/jgp.201210797.

Perspectives on: SGP symposium on mitochondrial physiology and medicine: mitochondrial proteome design: from molecular identity to pathophysiological regulation

Affiliations

Perspectives on: SGP symposium on mitochondrial physiology and medicine: mitochondrial proteome design: from molecular identity to pathophysiological regulation

Jun Zhang et al. J Gen Physiol. 2012 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Milestones in mitochondrial research. Representative milestones in mitochondrial research, including mitochondrial function, structure, and mitochondrial medicine, are listed in a chronological sequence (1890–current). Our apologies to those not represented in this timeline.
Figure 2.
Figure 2.
Schematic overview of mitochondrial subproteomes in health and disease. This figure contextualizes mitochondrial proteomes to their biological pathways and the consequences of the proteome compositions to clinical phenotypes. Mitochondrial pathways responsible for fundamental cellular functions within the cell, including OXPHOS, TCA cycle, β oxidation, apoptosis, proteolysis, redox, protein import, and calcium regulation, are detailed. Other mitochondrial functions related to specific cell types are not listed. Within each mitochondrial subproteome, the first number represents the total number of proteins associated with its function (the number of proteins was collected in our previous study; Zhang et al., 2008); the next number inside the parentheses (*) signifies the portion of the total proteins in this particular subproteome reported to be implicated in metabolic diseases.
Figure 3.
Figure 3.
Current state-of-the-art technology platform to characterize mitochondrial proteomes. This figure depicts the current technology platform used to characterize mitochondrial proteomes from model systems, including mitochondrial preparation, protein/peptide fractionations, MS instrumentation, protein identification/PTM analyses, protein quantification, and data validation.

References

    1. Alonso J., Rodriguez J.M., Baena-López L.A., Santarén J.F. 2005. Characterization of the Drosophila melanogaster mitochondrial proteome. J. Proteome Res. 4:1636–1645 10.1021/pr050130c - DOI - PubMed
    1. Balaban R.S. 2010. The mitochondrial proteome: a dynamic functional program in tissues and disease states. Environ. Mol. Mutagen. 51:352–359 - PMC - PubMed
    1. Baseler W.A., Dabkowski E.R., Williamson C.L., Croston T.L., Thapa D., Powell M.J., Razunguzwa T.T., Hollander J.M. 2011. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300:R186–R200 10.1152/ajpregu.00423.2010 - DOI - PMC - PubMed
    1. Boja E.S., Phillips D., French S.A., Harris R.A., Balaban R.S. 2009. Quantitative mitochondrial phosphoproteomics using iTRAQ on an LTQ-Orbitrap with high energy collision dissociation. J. Proteome Res. 8:4665–4675 10.1021/pr900387b - DOI - PMC - PubMed
    1. Bulteau A.L., Bayot A. 2011. Mitochondrial proteases and cancer. Biochim. Biophys. Acta. 1807:595–601 10.1016/j.bbabio.2010.12.011 - DOI - PubMed

Publication types